Skip to main content
. 2023 Aug 9;29(9):1136–1148. doi: 10.1177/13524585231189671

Table 2.

Considerations related to use of data linkage in clinical trials.

Advantages Disadvantages Other considerations
• Low burden on participants and trial sites • Endpoints limited to those captured in the data source. Complex clinical, performance-based, and imaging measures often not captured • Participant consent
• Comparatively low cost to primary data collection • Endpoints need to be validated and may not be available across all jurisdictions of interest • Nature of linkage (probabilistic or deterministic)
• May minimize selection bias and loss to follow-up if all participants in prior trial agree to participate 51 • Healthcare use may differ due to participant characteristics unrelated to the intervention • Completeness and accuracy
• Timing of extensive phase relative to parent trial
• Can establish external comparator group 52 • Availability of standardized definitions for variables to be used 53
• Ability to capture outcomes non-traditional outcomes such as admission to long-term care and use of social services • Time and administrative burden of data access and regional variation in access processes